Landmark Decision: Nicotine Replacement Therapy Available in Retail Stores

Market by 2FIRSTS.ai
May.16.2024
Landmark Decision: Nicotine Replacement Therapy Available in Retail Stores
Court ruling allows nicotine replacement therapy (NRT) to be sold in retail stores, boosting accessibility and effectiveness in smoking cessation.

According to eHealth's report on May 15th, the latest court ruling allows Nicotine Replacement Therapy (NRT) to be sold in retail stores, expanding the availability of this breakthrough treatment. This milestone decision highlights the effectiveness of NRT in aiding individuals in the process of quitting smoking, and its prominent position on the national essential medicines list since 2022. This legal recognition further strengthens its core role in public health programs aimed at controlling tobacco use.

 

Prominent experts in the medical field have praised this ruling, calling it a significant advancement. Dr. Chandrakant S Pandav, former head of the Community Medicine Department at the All India Institute of Medical Sciences (AIIMS) and recipient of the Lotus Award, commended the decision, emphasizing the importance of NRT in providing essential support for smokers looking to quit.

 

He stated, "This decision marks a significant shift in the concept of nicotine replacement therapy (NRT). For smokers looking to quit, NRT is a safe and effective tool, and this ruling rightfully acknowledges that fact. NRT plays a crucial role in providing necessary support for smokers to gradually reduce nicotine intake and achieve a smoke-free life, which is a goal that many smokers aspire to reach. The recent lifting of the ban and increased accessibility will have a positive impact on smoking cessation.

 

A recent court ruling marks a significant shift in historical viewpoints, as NRT has now been removed from the 1919 Poisons Act, signaling a change in direction for smoking cessation strategies. By acknowledging the value of NRT and making it more widely available, this decision has the potential to save countless lives and create a healthier society.

 

Dr. Niranjan Naik, head of oncological surgery at the Indian Fortis Memorial Research Institute (FMRI), has emphasized the transformative potential of increasing the accessibility of Nicotine Replacement Therapy (NRT). He stated, "This decision is a game-changer, as it paves the way for making NRT more widespread. NRT is a safe and effective tool, widely recognized as the most effective form of smoking cessation aid. By allowing for its wider availability, we can empower millions of smokers who truly want to quit but struggle with withdrawal symptoms. Enhancing the accessibility of NRT can greatly improve public health outcomes and bring a healthier future for our communities. Availability in retail stores will help people on their path to quitting smoking.

 

According to data from the World Health Organization (WHO), over one million people die each year in India alone due to smoking. However, Nicotine Replacement Therapy (NRT) is providing a glimmer of hope in the battle against tobacco addiction. NRT offers controlled doses of nicotine in various forms such as gum, patches, inhalers, and lozenges to help curb cravings and make the transition to a smoke-free life easier. Progress towards wider availability of NRT could lead to significant advancements in anti-smoking efforts, ultimately leading to a healthier, smoke-free India.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts’ Nine Global Turning Points: How 2025 Reshaped the Nicotine Industry
2Firsts’ Nine Global Turning Points: How 2025 Reshaped the Nicotine Industry
In 2025, the global nicotine industry reached a critical turning point. Regulatory realignment, category shifts, capital repositioning and technological intervention unfolded in parallel, loosening old structures while new ones took shape. 2Firsts reviews nine pivotal events that reshaped the industry’s trajectory.
Jan.14
France’s ANSES warns vaping carries health risks, urges limiting e-cigarette use to smoking cessation
France’s ANSES warns vaping carries health risks, urges limiting e-cigarette use to smoking cessation
France’s National Agency for Food, Environmental and Occupational Health & Safety (ANSES) says vaping poses health risks because users inhale toxic or harmful substances, even if e-cigarettes are generally considered less harmful than cigarettes.
Feb.04 by 2FIRSTS.ai
Korea’s MFDS sets 2026 plan to manage and disclose harmful constituents in tobacco products
Korea’s MFDS sets 2026 plan to manage and disclose harmful constituents in tobacco products
South Korea’s Ministry of Food and Drug Safety (MFDS) said it has established its 2026 work plan to systematically manage harmful constituents in tobacco products and disclose related information under the Tobacco Harmfulness Management Act, which took effect in November 2025.
Jan.16 by 2FIRSTS.ai
Product | OXBAR Lists GOSLIM Disposable Vape on Its Website, Featuring Embedded Leather and a Slim Display Window Design
Product | OXBAR Lists GOSLIM Disposable Vape on Its Website, Featuring Embedded Leather and a Slim Display Window Design
OXBAR has updated its official website and listed a new disposable product, GOSLIM. The device is rated at 26,000 puffs, measures 40 × 22 × 110 mm, and weighs about 75 g, featuring an “embedded leather” exterior design. It supports two power modes—ECO and BOOST—and includes a digital display showing remaining battery percentage, remaining e-liquid level, and the active mode.
Jan.21 by 2FIRSTS.ai
IQOS Partners with Mexico’s Zamna Festival; PMI Says Adult User Base Tops 140,000
IQOS Partners with Mexico’s Zamna Festival; PMI Says Adult User Base Tops 140,000
Philip Morris International (PMI) said IQOS, via its “IQOS Curious X” platform, has entered a global partnership with the Zamna music festival in Tulum, Mexico, with the collaboration making its on-site debut during Zamna 2026 and targeting adult nicotine users. PMI said IQOS has more than 34 million users worldwide, while the number of adult consumers in Mexico has surpassed 140,000.
Jan.15 by 2FIRSTS.ai
Philip Morris International Opens IQOS Flagship Boutique in the Philippines, Featuring an IQOS Scent Experience Zone
Philip Morris International Opens IQOS Flagship Boutique in the Philippines, Featuring an IQOS Scent Experience Zone
PMFTC, the Philippine affiliate of Philip Morris International (PMI), opened an IQOS flagship boutique on December 19 in the Ayala business district of Makati City, the Philippines. Positioned as a multi-sensory, immersive retail space, the store is designed for legal-aged nicotine users. It features the Philippines’ first IQOS Scent Experience zone and also showcases the upcoming IQOS x ISABEL collaboration.
Dec.29 by 2FIRSTS.ai